Microglia, amyloid and dementia in alzheimer disease. A correlative study - PubMed (original) (raw)
Microglia, amyloid and dementia in alzheimer disease. A correlative study
Y M Arends et al. Neurobiol Aging. 2000 Jan-Feb.
Abstract
To elucidate the role of microglia in Alzheimer's disease, a clinicopathological study was performed involving 26 cases, the mental status of which had been studied pre mortem by the Blessed test score (BTS). We measured the volume density of CD 68 immunoreactive (IR) microglia, congophilic plaques and Abeta deposits, and the numerical density of neurofibrillary tangles (NFT) in a sample of Area 9 (middle frontal gyrus). Dementia was significantly correlated only with the volume density of Abeta deposits and the numerical density of NFT. The volume densities of microglia and congophilic plaques were strongly correlated. With the intellectual status used as a time scale, IR microglia and amyloid deposits appeared almost simultaneously at an early stage in the pathological cascade and decreased, whereas Abeta and NFT were still accumulating. The intellectual deficit seemed to be more significantly related to the latter two lesions than to the microglia-amyloid complex, that was visible at an earlier stage (around BTS = 15).
Similar articles
- Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD. Nagy Z, et al. Dementia. 1995 Jan-Feb;6(1):21-31. doi: 10.1159/000106918. Dementia. 1995. PMID: 7728216 - Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
Koller EJ, Ibanez KR, Vo Q, McFarland KN, Gonzalez De La Cruz E, Zobel L, Williams T, Xu G, Ryu D, Patel P, Giasson BI, Prokop S, Chakrabarty P. Koller EJ, et al. Neuropathol Appl Neurobiol. 2022 Feb;48(2):e12779. doi: 10.1111/nan.12779. Epub 2021 Dec 10. Neuropathol Appl Neurobiol. 2022. PMID: 34825397 Free PMC article. - Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ, Jones G, Cranston A, Gardner H, Kanaan NM, Platt B. Koss DJ, et al. Acta Neuropathol. 2016 Dec;132(6):875-895. doi: 10.1007/s00401-016-1632-3. Epub 2016 Oct 21. Acta Neuropathol. 2016. PMID: 27770234 Free PMC article. - The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
Armstrong RA. Armstrong RA. Folia Neuropathol. 2009;47(4):289-99. Folia Neuropathol. 2009. PMID: 20054780 Review. - A critical analysis of the 'amyloid cascade hypothesis'.
Armstrong RA. Armstrong RA. Folia Neuropathol. 2014;52(3):211-25. Folia Neuropathol. 2014. PMID: 25310732 Review.
Cited by
- Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM, Tanis KQ, Gandhi P, Malkov V, Marcus J, Pearson M, Stevens R, Gilliland J, Ware C, Mahadomrongkul V, O'Loughlin E, Zeballos G, Smith R, Howell BJ, Klappenbach J, Kennedy M, Mirescu C. Rothman SM, et al. J Neuroinflammation. 2018 Sep 6;15(1):256. doi: 10.1186/s12974-018-1265-7. J Neuroinflammation. 2018. PMID: 30189875 Free PMC article. - NLRP3 inflammasome activation and pyroptosis are dispensable for tau pathology.
Paesmans I, Van Kolen K, Vandermeeren M, Shih PY, Wuyts D, Boone F, Garcia Sanchez S, Grauwen K, Van Hauwermeiren F, Van Opdenbosch N, Lamkanfi M, van Loo G, Bottelbergs A. Paesmans I, et al. Front Aging Neurosci. 2024 Sep 24;16:1459134. doi: 10.3389/fnagi.2024.1459134. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39381137 Free PMC article. - Innate immunity in Alzheimer's disease: a complex affair.
Guillot-Sestier MV, Town T. Guillot-Sestier MV, et al. CNS Neurol Disord Drug Targets. 2013 Aug;12(5):593-607. doi: 10.2174/1871527311312050008. CNS Neurol Disord Drug Targets. 2013. PMID: 23574177 Free PMC article. Review. - The significance of neuroinflammation in understanding Alzheimer's disease.
Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ. Eikelenboom P, et al. J Neural Transm (Vienna). 2006 Nov;113(11):1685-95. doi: 10.1007/s00702-006-0575-6. Epub 2006 Oct 13. J Neural Transm (Vienna). 2006. PMID: 17036175 Review. - Movement disorders: neurodevelopment and neurobehavioural expression.
Archer T, Beninger RJ. Archer T, et al. J Neural Transm (Vienna). 2007;114(4):XXXIII-XLI. doi: 10.1007/s00702-006-0572-9. Epub 2006 Oct 6. J Neural Transm (Vienna). 2007. PMID: 17024325 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical